These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24374121)

  • 1. Image-based evaluations of distribution and cytotoxicity of Irinotecan (CPT-11) in a multi-compartment micro-cell coculture device.
    Nakayama H; Kimura H; Fujii T; Sakai Y
    J Biosci Bioeng; 2014 Jun; 117(6):756-62. PubMed ID: 24374121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of camptothecin derivatives in a primary culture system of rat hepatocytes.
    Fulco RA; Costa C; Germanò MP; Torre EA; Viscomi MG; Salimbeni V; Maisano R; Giudice A; Costa G
    J Chemother; 2000 Aug; 12(4):345-51. PubMed ID: 10949985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of CPT-11 hydrolysis by human liver carboxylesterase isoforms hCE-1 and hCE-2.
    Humerickhouse R; Lohrbach K; Li L; Bosron WF; Dolan ME
    Cancer Res; 2000 Mar; 60(5):1189-92. PubMed ID: 10728672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polydimethylsiloxane SlipChip for mammalian cell culture applications.
    Chang CW; Peng CC; Liao WH; Tung YC
    Analyst; 2015 Nov; 140(21):7355-65. PubMed ID: 26381390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: application to cellular metabolism and accumulation studies.
    Hu ZP; Yang XX; Chen X; Chan E; Duan W; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):575-80. PubMed ID: 17270505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
    Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
    Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice.
    Allegrini G; Goulette FA; Darnowski JW; Calabresi P
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):261-6. PubMed ID: 14658007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Irinotecan pharmacokinetics].
    Chabot GG; Robert J; Lokiec F; Canal P
    Bull Cancer; 1998 Dec; Spec No():11-20. PubMed ID: 9932079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies.
    Viravaidya K; Shuler ML
    Biotechnol Prog; 2004; 20(2):590-7. PubMed ID: 15059006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ micropatterning technique by cell crushing for co-cultures inside microfluidic biochips.
    Leclerc E; El Kirat K; Griscom L
    Biomed Microdevices; 2008 Apr; 10(2):169-77. PubMed ID: 17849187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective conversion of irinotecan to SN-38 after intratumoral drug delivery to an intracranial murine glioma model in vivo. Laboratory investigation.
    Wang W; Ghandi A; Liebes L; Louie SG; Hofman FM; Schönthal AH; Chen TC
    J Neurosurg; 2011 Mar; 114(3):689-94. PubMed ID: 20415520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38.
    Dodds HM; Haaz MC; Riou JF; Robert J; Rivory LP
    J Pharmacol Exp Ther; 1998 Jul; 286(1):578-83. PubMed ID: 9655905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camptothecin analogs in malignant gliomas: comparative analysis and characterization.
    Sampath P; Amundson E; Wall ME; Tyler BM; Wani MC; Alderson LM; Colvin M; Brem H; Weingart JD
    J Neurosurg; 2003 Mar; 98(3):570-7. PubMed ID: 12650430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.
    Zastre J; Anantha M; Ramsay E; Bally M
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):91-102. PubMed ID: 17009029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance.
    Kanzawa F; Sugimoto Y; Minato K; Kasahara K; Bungo M; Nakagawa K; Fujiwara Y; Liu LF; Saijo N
    Cancer Res; 1990 Sep; 50(18):5919-24. PubMed ID: 2168285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecin analogues with enhanced antitumor activity at acidic pH.
    Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
    Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11).
    Potter PM; Pawlik CA; Morton CL; Naeve CW; Danks MK
    Cancer Res; 1998 Jun; 58(12):2646-51. PubMed ID: 9635592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors.
    Hattori Y; Shi L; Ding W; Koga K; Kawano K; Hakoshima M; Maitani Y
    J Control Release; 2009 May; 136(1):30-7. PubMed ID: 19331859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model.
    Cao S; Black JD; Troutt AB; Rustum YM
    Cancer Res; 1998 Aug; 58(15):3270-4. PubMed ID: 9699654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.
    Inoue Y; Tanaka K; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
    Int J Oncol; 2006 Feb; 28(2):479-86. PubMed ID: 16391804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.